Hurthle Cell Thyroid Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-24
Clinical Trial Update: 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating the radiopharmaceutical 177Lu-DOTA-EB-TATE in adults with metastatic, radioactive iodine non-responsive Hurthle…